Difference between revisions of "AstraZeneca"
| Line 13: | Line 13: | ||
[[Sourcewatch: Public Affairs Council]] | [[Sourcewatch: Public Affairs Council]] | ||
| − | [http://www.bitc.org.uk Business in the Community | + | [http://www.bitc.org.uk Business in the Community] |
| − | [http://www.ilsi.org International Life Sciences | + | [http://www.ilsi.org International Life Sciences] |
[[Sourcewatch: Centre for European Reform]] | [[Sourcewatch: Centre for European Reform]] | ||
| − | [http://www.pac.org/fpa Foundation for Public Affairs | + | [http://www.pac.org/fpa Foundation for Public Affairs] |
[[Sourcewatch: Conference Board]] | [[Sourcewatch: Conference Board]] | ||
| − | [http://www.conference-board.org/pdf_free/councils/314Roster.pdf European Council on Corporate Communications (Conference Board) | + | [http://www.conference-board.org/pdf_free/councils/314Roster.pdf European Council on Corporate Communications (Conference Board)] |
| − | [http://www.conference-board.org/memberservices/councilsDetailUS.cfm?Council_ID=147 Council of Chief Risk Officers (Conference Board | + | [http://www.conference-board.org/memberservices/councilsDetailUS.cfm?Council_ID=147 Council of Chief Risk Officers (Conference Board] |
| − | [http://www.ert.be/ European Round Table of Industrialists | + | [http://www.ert.be/ European Round Table of Industrialists] |
[[Sourcewatch: Science Media Centre]] | [[Sourcewatch: Science Media Centre]] | ||
| Line 34: | Line 34: | ||
==CSR (Corporate Social Responsibility) Ventures== | ==CSR (Corporate Social Responsibility) Ventures== | ||
| + | |||
| + | ‘AstraZeneca Science Teaching Trust which in 2001 sponsored the ‘Little Book of Experiments’ which was distributed to UK primary schools as part of the National year of Science. programme. | ||
| + | |||
| + | In 2001, AstraZeneca’s overall community spend totalled $19 million.’ (Source: AstraZeneca Annual Review 2001, page 23) | ||
| + | |||
| + | |||
| + | [http://www.astrazeneca.com/mainnav1/about/cr/s_projects/project_list/c_projects_list/project-uk-cal-00-8.asp‘AZ UK’s CALM Programme – AstraZeneca UK’s CALM Programme] is designed to promote well-being by helping employees achieve the right balance between work and leisure. The Programme aims to help people recognise signs of stress, and to provide routes of confidential support.’ | ||
| + | |||
| + | [http://www.astrazeneca.com/mainnav1/about/cr/s_projects/project_list/c_projects_list/project-uk-hea-01-1.asp‘The Balanced Living Charter] launched in 2001, developed in response to the leadership team’s concern about stress-related illness and is used as a basis for action to improve the management of pressure. Its creation was intended for AstraZeneca staff working at the UK R&D sites to obtain the appropriate balance between work and home life and is intended to be used as a basis for action to improve the management of stress.’ | ||
Revision as of 17:23, 18 November 2005
Company Name:
AstraZeneca Plc[1]
Market Capital £m: 2000: 2001: 56,334.9 FT UK 500 (2001)
Turnover £m: 2001: 12,325.0 FT UK 500 (2001)
Organisations in which membership is held:
Sourcewatch: Public Affairs Council
Sourcewatch: Centre for European Reform
European Council on Corporate Communications (Conference Board)
Council of Chief Risk Officers (Conference Board
European Round Table of Industrialists
Sourcewatch: Science Media Centre
Sourcewatch: Royal Institute of International Affairs
CSR (Corporate Social Responsibility) Ventures
‘AstraZeneca Science Teaching Trust which in 2001 sponsored the ‘Little Book of Experiments’ which was distributed to UK primary schools as part of the National year of Science. programme.
In 2001, AstraZeneca’s overall community spend totalled $19 million.’ (Source: AstraZeneca Annual Review 2001, page 23)
UK’s CALM Programme – AstraZeneca UK’s CALM Programme is designed to promote well-being by helping employees achieve the right balance between work and leisure. The Programme aims to help people recognise signs of stress, and to provide routes of confidential support.’
Balanced Living Charter launched in 2001, developed in response to the leadership team’s concern about stress-related illness and is used as a basis for action to improve the management of pressure. Its creation was intended for AstraZeneca staff working at the UK R&D sites to obtain the appropriate balance between work and home life and is intended to be used as a basis for action to improve the management of stress.’
